This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1987 Nov;5(11):1711-2.

doi: 10.1200/JCO.1987.5.11.1711.

Advanced non-small-cell lung cancer: to treat or not to treat?

PMID: 2824704
DOI: 10.1200/JCO.1987.5.11.1711

Clinical Trial

Advanced non-small-cell lung cancer: to treat or not to treat?

H H Hansen. J Clin Oncol. 1987 Nov.

. 1987 Nov;5(11):1711-2.

doi: 10.1200/JCO.1987.5.11.1711.

Author

PMID: 2824704
DOI: 10.1200/JCO.1987.5.11.1711

No abstract available

PubMed Disclaimer

Similar articles

[Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Moro D. Moro D. Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S22-4. Rev Pneumol Clin. 2001. PMID: 11924237 Review. French. No abstract available.
[Latest therapeutic strategy for stage IV non-small cell lung cancer].
Kawate N. Kawate N. Nihon Rinsho. 2002 May;60 Suppl 5:490-3. Nihon Rinsho. 2002. PMID: 12101720 Review. Japanese. No abstract available.
[Treatment of small cell lung cancer].
Ueoka H, Ohnoshi T. Ueoka H, et al. Gan To Kagaku Ryoho. 1994 Nov;21(15):2571-7. Gan To Kagaku Ryoho. 1994. PMID: 7979415 Review. Japanese.
[Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F. Mornex F. Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S29-32. Rev Pneumol Clin. 2001. PMID: 11924239 Review. French. No abstract available.
[Combined-modality therapy for lung cancer].
Miura S, Yamamoto N. Miura S, et al. Nihon Rinsho. 2010 Jun;68(6):1121-8. Nihon Rinsho. 2010. PMID: 20535966 Review. Japanese.

See all similar articles

Cited by

A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
Crino L, Tonato M, Darwish S, Meacci ML, Corgna E, Di Costanzo F, Buzzi F, Fornari G, Santi E, Ballatori E, et al. Crino L, et al. Cancer Chemother Pharmacol. 1990;26(1):52-6. doi: 10.1007/BF02940294. Cancer Chemother Pharmacol. 1990. PMID: 2157554 Clinical Trial.
Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill.
Wilbur DW, Camacho ES, Hilliard DA, Dill PL, Weisenthal LM. Wilbur DW, et al. Br J Cancer. 1992 Jan;65(1):27-32. doi: 10.1038/bjc.1992.5. Br J Cancer. 1992. PMID: 1310250 Free PMC article.
Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
Lissoni P, Tisi E, Barni S, Ardizzoia A, Rovelli F, Rescaldani R, Ballabio D, Benenti C, Angeli M, Tancini G, et al. Lissoni P, et al. Br J Cancer. 1992 Jul;66(1):155-8. doi: 10.1038/bjc.1992.234. Br J Cancer. 1992. PMID: 1322155 Free PMC article. Clinical Trial.
Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer.
Fukuda M, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Hara K, Saijo N. Fukuda M, et al. Cancer Chemother Pharmacol. 1990;26(6):393-6. doi: 10.1007/BF02994087. Cancer Chemother Pharmacol. 1990. PMID: 2171794 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information